Sulfadoxine is an ultra-long-acting sulfa drug for the treatment of meningitis, urinary tract infection, etc.

The global Sulfadoxine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Sulfadoxine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sulfadoxine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Jinshen Medical
Luotian Xinpusheng Pharmaceutical
Changshu Nanhu Industrial
Taicang Pharmaceutical Factory
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
USP25
BP2000
Other

Segment by Application
Hemolytic Streptococcal Infection
Pneumococcal Infection
Meningococcal Infection
Other